Pharma Globenewswire

Eosinophilic Esophagitis Therapeutics Market Size (7MM) was ~USD 901 Million in 2025 and is projected to reach ~USD 3,543 Million growing at 12.9% CAGR by 2036, estimates DelveInsight

26 May 2026

DelveInsight’s “Eosinophilic Esophagitis Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of Eosinophilic Esophagitis, historical and forecasted epidemiology, as well as the Eosinophilic Esophagitis market trends in the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom,

Uncategorised

Merkel Cell Carcinoma Market: Emerging Therapies, Epidemiology, Key Players, and Treatment Landscape Insights Through 2034

26 May 2026

According to DelveInsight, in 2024, Merkel Cell Carcinoma (MCC) accounted for approximately 4,500 cases across the 7MM. The Merkel Cell Carcinoma market is undergoing significant transformation, driven by expanding immunotherapy adoption and a rich clinical pipeline. MCC is highly responsive to radiotherapy,

Uncategorised

Psoriatic Arthritis Therapeutics Market Size (7MM) projected to grow at significant CAGR by 2034, estimates DelveInsight

25 May 2026

DelveInsight’s “Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of Psoriatic Arthritis, historical and forecasted epidemiology, as well as the Psoriatic Arthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom),

Uncategorised

Wet Age-Related Macular Degeneration Market: Global Trends, Epidemiology, Emerging Therapies, and Growth Forecast Across the 7MM Through 2036

25 May 2026

The Wet Age-Related Macular Degeneration market continues to demonstrate robust expansion across major markets worldwide. In 2023, the market size of Wet Age-Related Macular Degeneration (Wet AMD) was highest in the US among the 7MM, accounting for approximately USD 2,599 million, which

Uncategorised

Inflammatory Bowel Disease Therapeutics Market Size in the 7MM is anticipated to increase at a significant CAGR by 2036, estimates DelveInsight

22 May 2026

DelveInsight’s “Inflammatory Bowel Disease Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of the Inflammatory Bowel Disease, historical and forecasted epidemiology as well as the Inflammatory Bowel Disease market trends in the United States, EU4 (Germany, France, Italy, and

Uncategorised

Crohn’s Disease Market Set for Significant Growth: Rising Prevalence, Biologic Innovations, and Emerging Therapies Drive Expansion Through 2034

22 May 2026

The Crohn’s Disease market is experiencing robust expansion across the 7 Major Markets (7MM). The market size is expected to grow from USD 11,367 million in 2025 to USD 16,840 million in 2034, reflecting a CAGR of 4.40%. This steady growth is

Market Insights·News·Reports

Infusion Pumps Market Projected to Grow at a Robust CAGR of ~10% by 2032

21 May 2026

Infusion Pumps Companies are B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corporation, Medtronic plc., Fresenius Kabi, CareFusion Corporation, Smiths Medical, Koninklijke Philips NV, Micrel Medical Devices SA, Terumo Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., F. Hoffmann-La Roche Ltd., Johnson

Clinical Trials·News·Reports

Alcohol Use Disorder Pipeline Set for Transformational Progress by 2026 with 25+ Therapies

21 May 2026

Alcohol Use Disorder (AUD) companies such as Adial Pharmaceuticals, Imbrium Therapeutics, BioCorRx Pharmaceuticals, Beckley Psytech, Cybin, BioXcel Therapeutics, MediciNova, and others are actively redefining the future of addiction therapeutics through innovative drug development strategies, precision medicine approaches, and expanding clinical pipelines. DelveInsight’s,

Clinical Trials·News·Reports

Atopic Dermatitis Pipeline Set for Transformational Expansion by 2026 with 120+ Therapies

21 May 2026

Atopic Dermatitis companies such as Innocare Pharma, Apogee Therapeutics, Celldex Therapeutics, Aclaris Therapeutics, BioCryst Pharmaceuticals, Vanda Pharmaceuticals, and several others are actively reshaping the future of Atopic Dermatitis (AD) therapeutics through innovative drug development strategies, targeted immunological approaches, and a rapidly expanding

Latest

Eosinophilic Esophagitis Therapeutics Market Size (7MM) was ~USD 901 Million in 2025 and is projected to reach ~USD 3,543 Million growing at 12.9% CAGR by 2036, estimates DelveInsight

Merkel Cell Carcinoma Market: Emerging Therapies, Epidemiology, Key Players, and Treatment Landscape Insights Through 2034

Psoriatic Arthritis Therapeutics Market Size (7MM) projected to grow at significant CAGR by 2034, estimates DelveInsight

Inflammatory Bowel Disease Therapeutics Market Size in the 7MM is anticipated to increase at a significant CAGR by 2036, estimates DelveInsight

Crohn’s Disease Market Set for Significant Growth: Rising Prevalence, Biologic Innovations, and Emerging Therapies Drive Expansion Through 2034

Infusion Pumps Market Projected to Grow at a Robust CAGR of ~10% by 2032

Alcohol Use Disorder Pipeline Set for Transformational Progress by 2026 with 25+ Therapies

Atopic Dermatitis Pipeline Set for Transformational Expansion by 2026 with 120+ Therapies

Recent Posts

Banner

Newsletter

Authors